GLSHQ (Gelesis Holdings) Construction In Progress: $15.69 Mil (As of Jun. 2023)


What is Gelesis Holdings Construction In Progress?

Gelesis Holdings GLSHQ -99.00% Construction In Progress is $15.69 Mil as of Jun. 2023.

Gelesis Holdings's quarterly construction in progress declined from Dec. 2022 ($24.29 Mil) to Mar. 2023 ($15.65 Mil) but then increased from Mar. 2023 ($15.65 Mil) to Jun. 2023 ($15.69 Mil).

Gelesis Holdings's annual construction in progress increased from . 20 ($0.00 Mil) to Dec. 2021 ($22.10 Mil) and increased from Dec. 2021 ($22.10 Mil) to Dec. 2022 ($24.29 Mil).

Gelesis Holdings Construction In Progress Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Construction In Progress Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Construction In Progress
22.10 24.29

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.68 22.50 24.29 15.65 15.69

Gelesis Holdings Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $15.69 Mil mean?
Gelesis Holdings (GLSHQ) has a Construction In Progress of $15.69 Mil as of Jun. 2023. Construction in Progress records the amount of construction work that is not complete. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' Construction In Progress too high?
Gelesis Holdings' current Construction In Progress is $15.69 Mil.
How does Gelesis Holdings' Construction In Progress compare to RBSH and PPCB?
Gelesis Holdings' Construction In Progress of $15.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current Construction In Progress is $15.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Construction In Progress of $15.69 Mil. The current Construction In Progress is $15.69 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Construction In Progress is $15.69 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.